{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:28:53Z","timestamp":1768008533619,"version":"3.49.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jcyt.2019.04.056","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T08:15:19Z","timestamp":1568708119000},"page":"1007-1018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Umbilical cord\u2013derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data"],"prefix":"10.1016","volume":"21","author":[{"given":"Martina","family":"Colicchia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Beirne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-6771","authenticated-orcid":false,"given":"Mohsin","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8594-1499","authenticated-orcid":false,"given":"Deshan","family":"Weeraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaraj","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessry","family":"Veerapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lowdell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcyt.2019.04.056_bib0001","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0002","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jcyt.2019.04.056_bib0003","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0004","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.4238\/2015.April.10.11","article-title":"Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure","volume":"14","author":"Zhao","year":"2015","journal-title":"Genet Mol Res"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12015-011-9302-2","article-title":"Stem cells in the treatment of cardiovascular disease\u2014an overview","volume":"8","author":"Hotkar","year":"2012","journal-title":"Stem Cell Rev Reports"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14797\/mdcj-9-4-195","article-title":"Use of stem cells in heart failure treatment: where we stand and where we are going","volume":"9","author":"S\u00e1nchez","year":"2013","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"8","key":"10.1016\/j.jcyt.2019.04.056_bib0007","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.115.307676","article-title":"Cardiac stem cell treatment in myocardial infarctionnovelty and significance","volume":"118","author":"Zwetsloot","year":"2016","journal-title":"Circ Res"},{"issue":"16","key":"10.1016\/j.jcyt.2019.04.056_bib0008","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0009","series-title":"Cochrane Database of Systematic Reviews","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","author":"Fisher","year":"2014"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4252\/wjsc.v9.i4.68","article-title":"Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction","volume":"9","author":"Micheu","year":"2017","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0011","series-title":"Cochrane Database of Systematic Reviews","article-title":"Stem cell treatment for acute myocardial infarction","author":"Clifford","year":"2012"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13287-015-0010-8","article-title":"Challenges in identifying the best source of stem cells for cardiac regeneration therapy","volume":"6","author":"Dixit","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0013","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/scrt93","article-title":"Bone marrow mononuclear cells and acute myocardial infarction","volume":"3","author":"Arnous","year":"2012","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"10.1016\/j.jcyt.2019.04.056_bib0014","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jacc.2014.06.1175","article-title":"Translating Stem Cell Research to Cardiac Disease Therapies","volume":"64","author":"Rosen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0015","first-page":"81","article-title":"Cardiac tissue engineering and regeneration using cell-based therapy","volume":"8","author":"Shum-Tim","year":"2015","journal-title":"Stem Cells Cloning Adv Appl"},{"issue":"5411","key":"10.1016\/j.jcyt.2019.04.056_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells - current trends and future prospective","volume":"35","author":"Ullah","year":"2015","journal-title":"Biosci Rep"},{"issue":"22","key":"10.1016\/j.jcyt.2019.04.056_bib0018","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.jcyt.2019.04.056_bib0019","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.113.007412","article-title":"Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices","volume":"129","author":"Ascheim","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/340257","article-title":"Management of fibrosis: the mesenchymal stromal cells breakthrough","volume":"2014","author":"Usunier","year":"2014","journal-title":"Stem Cells Int"},{"issue":"3","key":"10.1016\/j.jcyt.2019.04.056_bib0021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"1680","key":"10.1016\/j.jcyt.2019.04.056_bib0022","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0017","article-title":"Cell-based therapy technology classifications and translational challenges","volume":"370","author":"Mount","year":"2015","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"8","key":"10.1016\/j.jcyt.2019.04.056_bib0023","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/014107680509800804","article-title":"Embryonic stem cells and tissue engineering: delivering stem cells to the clinic","volume":"98","author":"Vats","year":"2005","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0024","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.1016\/j.placenta.2011.06.010","article-title":"Wharton's jelly stem cells: future clinical applications","volume":"32","author":"Taghizadeh","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/150609","article-title":"Umbilical Cord Tissue-Derived Cells as Therapeutic Agents","volume":"2015","author":"Maslova","year":"2015","journal-title":"Stem Cells Int"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0026","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12015-012-9418-z","article-title":"The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord","volume":"9","author":"Bongso","year":"2013","journal-title":"Stem Cell Rev Reports"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue","year":"2014","journal-title":"World J Stem Cells"},{"issue":"12","key":"10.1016\/j.jcyt.2019.04.056_bib0028","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/1933719113488443","article-title":"Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential","volume":"20","author":"Messerli","year":"2013","journal-title":"Reprod Sci"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0029","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/scd.2014.0349","article-title":"Umbilical cord mesenchymal stromal cells affected by gestational diabetes mellitus display premature aging and mitochondrial dysfunction","volume":"24","author":"Kim","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm1391","article-title":"Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction","volume":"12","author":"Miyahara","year":"2006","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0031","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.07.009","article-title":"Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance","volume":"79","author":"Kim","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"26","key":"10.1016\/j.jcyt.2019.04.056_bib0032","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v22.i26.6036","article-title":"Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats","volume":"22","author":"Chai","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0033","doi-asserted-by":"crossref","first-page":"37566","DOI":"10.1038\/srep37566","article-title":"Umbilical cord-derived mesenchymal stem cells instruct monocytes towards an il10-producing phenotype by secreting IL6 and HGF","volume":"6","author":"Deng","year":"2016","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jcyt.2019.04.056_bib0034","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0035","first-page":"306","article-title":"Suggested indications of clinical practice guideline for stem cell-therapy in cardiovascular diseases: A stepwise appropriate use criteria for regeneration therapy","volume":"9","author":"Behjati","year":"2013","journal-title":"ARYA Atheroscler"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","article-title":"Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy","volume":"17","author":"Vrtovec","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9742034","article-title":"Umbilical cord-derived mesenchymal stem cells relieve hindlimb ischemia through enhancing angiogenesis in tree shrews","volume":"2016","author":"Yin","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0038","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-016-0032-3","article-title":"Neuroprotective effects of human umbilical cord-derived mesenchymal stem cells on periventricular leukomalacia-like brain injury in neonatal rats Inflammation and Regeneration","volume":"37","author":"Morioka","year":"2017","journal-title":"Inflamm Regen"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0039","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/scrt442","article-title":"Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly","volume":"5","author":"Amable","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cbin.10056","article-title":"Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow","volume":"37","author":"Balasubramanian","year":"2013","journal-title":"Cell Biol Int"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0041","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/scd.2014.0184","article-title":"Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway","volume":"24","author":"Kuchroo","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0042","doi-asserted-by":"crossref","first-page":"163","DOI":"10.15283\/ijsc16053","article-title":"Therapeutic potential of human mesenchymal stem cells for treating ischemic limb diseases","volume":"9","author":"Han","year":"2016","journal-title":"Int J stem cells"},{"issue":"11","key":"10.1016\/j.jcyt.2019.04.056_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111025","article-title":"Endothelium trans differentiated from Wharton's jelly mesenchymal cells promote tissue regeneration: potential role of soluble pro-angiogenic factors","volume":"9","author":"Aguilera","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jcyt.2019.04.056_bib0044","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.biocel.2012.12.001","article-title":"Proangiogenic features of Wharton's jelly-derived mesenchymal stromal\/stem cells and their ability to form functional vessels","volume":"45","author":"Choi","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13287-016-0418-9","article-title":"Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta","volume":"7","author":"Du","year":"2016","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2019.04.056_bib0046","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","article-title":"Wharton's jelly-derived cells are a primitive stromal cell population","volume":"26","author":"Troyer","year":"2008","journal-title":"Stem Cells"},{"issue":"5-6","key":"10.1016\/j.jcyt.2019.04.056_bib0047","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000094140","article-title":"Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia","volume":"17","author":"Moon","year":"2006","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0048","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pharmthera.2014.02.013","article-title":"Mesenchymal stem\/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis","volume":"143","author":"Bronckaers","year":"2014","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.jcyt.2019.04.056_bib0049","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","article-title":"Immune properties of human umbilical cord Wharton's jelly-derived cells","volume":"26","author":"Weiss","year":"2008","journal-title":"Stem Cells"},{"issue":"17","key":"10.1016\/j.jcyt.2019.04.056_bib0050","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1089\/scd.2013.0559","article-title":"Umbilical cord-derived mesenchymal stem cells instruct dendritic cells to acquire tolerogenic phenotypes through the IL-6-mediated upregulation of SOCS1","volume":"23","author":"Deng","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0051","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12964-014-0063-9","article-title":"Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity","volume":"12","author":"Chatterjee","year":"2014","journal-title":"Cell Commun Signal"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0052","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","article-title":"Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources","volume":"264","author":"Najar","year":"2010","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0053","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/keu316","article-title":"Umbilical cord mesenchymal stem cells inhibit the differentiation of circulating T follicular helper cells in patients with primary Sj\u00f6gren's syndrome through the secretion of indoleamine 2,3-dioxygenase","volume":"54","author":"Liu","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0054","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.matbio.2016.01.010","article-title":"Inflammation, fibrosis, and modulation of the process by mesenchymal stem\/stromal cells","volume":"51","author":"Prockop","year":"2016","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3232859","article-title":"Hepatocyte growth factor effects on mesenchymal stem cells derived from human arteries: a novel strategy to accelerate vascular ulcer wound healing","volume":"2016","author":"Valente","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajg.2017.05.012","article-title":"Comparative study on the effect of low intensity laser and growth factors on stem cells used in experimentally-induced liver fibrosis in mice","author":"Naguib","year":"2017","journal-title":"Arab J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0057","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocit.2014.12.001","article-title":"Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases","volume":"2","author":"Zhao","year":"2016","journal-title":"J Cell Immunother"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0058","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/ten.teb.2013.0664","article-title":"Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?","volume":"20","author":"El Omar","year":"2014","journal-title":"Tissue Eng Part B Rev"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0059","doi-asserted-by":"crossref","first-page":"48","DOI":"10.15283\/ijsc16063","article-title":"Cardioprotective effects of Wharton jelly derived mesenchymal stem cell transplantation in a rodent model of myocardial injury","volume":"10","author":"Gaafar","year":"2017","journal-title":"Int J Stem Cells"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0060","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.jcyt.2019.04.056_bib0061","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jcb.24057","article-title":"Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells","volume":"113","author":"Subramanian","year":"2012","journal-title":"J Cell Biochem"},{"issue":"11","key":"10.1016\/j.jcyt.2019.04.056_bib0062","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1634\/stemcells.2007-0417","article-title":"Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells","volume":"25","author":"Can","year":"2007","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0063","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/scrt477","article-title":"Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study","volume":"5","author":"Swamynathan","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0064","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.athoracsur.2006.10.066","article-title":"Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model","volume":"83","author":"Wu","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000331714","article-title":"Integration properties of Wharton's jelly-derived novel mesenchymal stem cells into ventricular slices of murine hearts","volume":"28","author":"Lupu","year":"2011","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0066","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/scrt394","article-title":"Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms","volume":"5","author":"Nascimento","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.jcyt.2019.04.056_bib0067","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MCA.0b013e3283640f00","article-title":"Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction","volume":"24","author":"Zhang","year":"2013","journal-title":"Coron Artery Dis"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0068","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12350-010-9326-z","article-title":"Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of 99(m)Tc-labeled cells activity","volume":"18","author":"Musialek","year":"2011","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0069","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCIMAGING.112.979633","article-title":"Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zoneclinical perspective","volume":"6","author":"Musialek","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1875043501104010028","article-title":"Wharton's jelly mesenchymal stem cells as off-the-shelf cellular therapeutics: a closer look into their regenerative and immunomodulatory properties","volume":"4","author":"Jyothi Prasanna","year":"2011","journal-title":"Open Tissue Eng Regen Med J"},{"issue":"12","key":"10.1016\/j.jcyt.2019.04.056_bib0071","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.jcyt.2017.08.004","article-title":"Umbilical cord mesenchymal stromal cell transplantations: A systemic analysis of clinical trials","volume":"19","author":"Can","year":"2017","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0072","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v6.i2.195","article-title":"Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility","volume":"6","author":"Nagamura-Inoue","year":"2014","journal-title":"World J Stem Cells"},{"issue":"7","key":"10.1016\/j.jcyt.2019.04.056_bib0073","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3727\/000000006783981611","article-title":"Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size","volume":"15","author":"Henning","year":"2006","journal-title":"Cell Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2019.04.056_bib0074","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.trsl.2012.02.004","article-title":"Human umbilical cord blood mononuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia","volume":"159","author":"Henning","year":"2012","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.jcyt.2019.04.056_bib0075","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/scd.2008.0023","article-title":"Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction","volume":"17","author":"Henning","year":"2008","journal-title":"Stem Cells Dev"},{"issue":"9","key":"10.1016\/j.jcyt.2019.04.056_bib0076","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3727\/096368907783338299","article-title":"Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size","volume":"16","author":"Henning","year":"2007","journal-title":"Cell Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2019.04.056_bib0077","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00395-011-0221-9","article-title":"Mesenchymal stromal cells mediate a switch to alternatively activated monocytes\/macrophages after acute myocardial infarction","volume":"106","author":"Dayan","year":"2011","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"10.1016\/j.jcyt.2019.04.056_bib0078","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1634\/stemcells.2007-0708","article-title":"Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation","volume":"26","author":"Chang","year":"2008","journal-title":"Stem Cells"},{"issue":"23","key":"10.1016\/j.jcyt.2019.04.056_bib0079","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1089\/scd.2013.0119","article-title":"Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts","volume":"22","author":"Martinez","year":"2013","journal-title":"Stem Cells Dev"},{"issue":"8","key":"10.1016\/j.jcyt.2019.04.056_bib0080","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5966\/sctm.2015-0298","article-title":"Human umbilical cord-derived mesenchymal stromal cells improve left ventricular function, perfusion, and remodeling in a porcine model of chronic myocardial ischemia","volume":"5","author":"Liu","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0081","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","article-title":"Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial","volume":"13","author":"Gao","year":"2015","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.jcyt.2019.04.056_bib0082","doi-asserted-by":"crossref","first-page":"H1385","DOI":"10.1152\/ajpheart.01167.2011","article-title":"Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences","volume":"303","author":"Zhang","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.jcyt.2019.04.056_bib0083","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.actbio.2014.03.013","article-title":"Umbilical-cord-blood-derived mesenchymal stem cells seeded onto fibronectin-immobilized polycaprolactone nanofiber improve cardiac function","volume":"10","author":"Kang","year":"2014","journal-title":"Acta Biomater"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0084","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13287-017-0472-y","article-title":"Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats","volume":"8","author":"Mao","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejcb.2015.11.003","article-title":"Human umbilical cord blood derived mesenchymal stem cells improve cardiac function in cTnT R141W transgenic mouse of dilated cardiomyopathy","volume":"95","author":"Gong","year":"2016","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0086","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijcard.2014.09.128","article-title":"Umbilical cord blood-derived mesenchymal stem cells: New therapeutic weapons for idiopathic dilated cardiomyopathy?","volume":"177","author":"Roura","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jcyt.2019.04.056_bib0087","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2006.10.003","article-title":"Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis","volume":"42","author":"Ohnishi","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.jcyt.2019.04.056_bib0088","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.3892\/mmr.2017.6454","article-title":"Human umbilical cord mesenchymal stem cells alleviate acute myocarditis by modulating endoplasmic reticulum stress and extracellular signal regulated 1\/2-mediated apoptosis","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.jcyt.2019.04.056_bib0089","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.jcyt.2019.04.056_bib0090","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.exphem.2005.07.003","article-title":"Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood","volume":"33","author":"Wagner","year":"2005","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0091","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jcyt.2019.04.056_bib0092","first-page":"100","article-title":"Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf \u201cunlimited\u201d therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study","volume":"11","author":"Musialek","year":"2015","journal-title":"Adv Interv Cardiol"},{"issue":"3","key":"10.1016\/j.jcyt.2019.04.056_bib0093","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2012.05.026","article-title":"Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)","volume":"164","author":"Mathiasen","year":"2012","journal-title":"Am Heart J"},{"issue":"27","key":"10.1016\/j.jcyt.2019.04.056_bib0094","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0095","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3892\/etm.2016.3748","article-title":"Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure","volume":"12","author":"Fang","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jcyt.2019.04.056_bib0096","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/761643","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury","volume":"2015","author":"Zhao","year":"2015","journal-title":"Stem Cells Int"},{"issue":"6","key":"10.1016\/j.jcyt.2019.04.056_bib0097","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1472-6483(10)60159-9","article-title":"Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy","volume":"16","author":"Ichim","year":"2008","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"10.1016\/j.jcyt.2019.04.056_bib0098","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.jcyt.2019.04.056_bib0099","first-page":"1369","article-title":"Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells: a novel treatment in patients of acute myocardial infarction","volume":"65","author":"Bilal","year":"2015","journal-title":"J Pak Med Assoc"},{"issue":"5","key":"10.1016\/j.jcyt.2019.04.056_bib0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12015-015-9601-0","article-title":"Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A study protocol of a phase 1\/2, controlled and randomized trial in combination with coronary artery bypass grafting","volume":"11","author":"Can","year":"2015","journal-title":"Stem Cell Rev"},{"issue":"11","key":"10.1016\/j.jcyt.2019.04.056_bib0101","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2174\/1381612821666141126100636","article-title":"Safety and efficacy of intracoronary human umbilical cord-derived mesenchymal stem cell treatment for very old patients with coronary chronic total occlusion","volume":"21","author":"Li","year":"2015","journal-title":"Curr Pharm Des."}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324919304621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324919304621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:39:21Z","timestamp":1761442761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324919304621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1465324919304621"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2019.04.056","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Umbilical cord\u2013derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2019.04.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}